Cibus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.37

-0.06 (-4.20%)

As of Jun 30, 10:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,119.0% upside

Low Target $22.94

Average Target $30.40

High Target $39.68

Current Price $1.37

Current
$1.37

Target
$30.40

$22.94 $30.40 avg $39.68

Scenario Analysis

Bear Case

$22.94

1,574.5%

Low target

Base Case

$30.40

+2,119.0%

Avg target

Bull Case

$39.68

+2,796.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.19

-67.3% from high

52-Week Low

$1.09

+25.7% from low

Target vs 52W High

$30.40

+625.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%